Skip to content
Screener

Mannkind MNKD Debt-to-equity

Debt-to-equity at other companies

Eli Lilly logo
Eli LillyLLY
1.6×-0.6×
LQD
Liquidia CorporationLQDA
0.1×-0.1×
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
0.3×-0.1×
Omada Health logo
Omada HealthOMDA
0.1×—
Viking Therapeutics logo
Viking TherapeuticsVKTX
0×0.0×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
0×0.0×

Other financials

Income statement

See full
Revenue$109.4M+42.9%
Gross profit$95.0M+32.0%
Operating income-$350.0K-107%
Net income-$19.0M-2,949%
EPS (diluted)-$0.06—

Balance sheet

See full
Cash & equivalents$52.9M-7.2%
Total debt$11.8M-7.5%
Total equity-$67.2M-22.1%
Total assets$732.3M+77.9%

Cash flow

See full
Operating cash flow-$18.4M-305%
CapEx$5.1M+355%
Free cash flow-$23.5M-399%

Valuation

See full
Market cap$1.25B+17.8%
Enterprise value$1.21B+18.9%
P/S3.2×-0.3×

Profitability

See full
Gross margin89.8%-4.8pp
Operating margin23.3%+3.1pp
Net margin9.3%—
FCF margin13.8%—

Returns & leverage

See full
Return on equity44.2%—
Current ratio1.7×-0.8×